Calvo Romero J M, Morales Pérez F, Alvarez Barreiro J A, Díaz Pérez de Madrid J
Servicio de Medicina Interna, Hospital Regional Universitario Infanta Cristina, Badajoz.
Rev Clin Esp. 1999 Jan;199(1):25-7.
To determine the usefulness of ketoconazole for the control of arterial hypertension (AH) in Cushing syndrome (CS) as temporary treatment.
Fifteen cases of CS were collected (eleven cases of Cushing disease, two cases of ectopic secretion of ACTH, one case of adrenal adenoma, and one case of adrenal carcinoma). The clinical characteristics as well as laboratory data of patients with AH and the response to therapy were studied.
Six patients (40%) had AH. A significant difference was observed of an older age, a higher frequency of association with diabetes mellitus and a higher 24 hour free urine cortisol (FUC) for patients with AH compared with non hypertensive patients. Ketoconazole was efficient for controlling AH in five cases, and in all of them the return to normal levels of 24 hour FUC was achieved. A failure of AH control under treatment with ketoconazole occurred in the only case of adrenal carcinoma. There was no significant secondary adverse reaction to ketoconazole.
Ketoconazole is an efficient drug for the control of AH in CS and is well tolerated. In our series, the return to normal levels of FUC was associated with control of AH.
确定酮康唑作为临时治疗药物在库欣综合征(CS)中控制动脉高血压(AH)的有效性。
收集了15例CS患者(11例库欣病、2例促肾上腺皮质激素异位分泌、1例肾上腺腺瘤和1例肾上腺皮质癌)。研究了AH患者的临床特征、实验室数据以及对治疗的反应。
6例患者(40%)患有AH。与非高血压患者相比,AH患者在年龄、糖尿病合并频率以及24小时尿游离皮质醇(FUC)水平方面存在显著差异。酮康唑在5例患者中有效控制了AH,并且所有这些患者的24小时FUC均恢复到正常水平。酮康唑治疗下AH控制失败仅发生在肾上腺皮质癌这一病例中。酮康唑没有明显的继发不良反应。
酮康唑是控制CS中AH的有效药物,耐受性良好。在我们的系列研究中,FUC恢复到正常水平与AH的控制相关。